Cryoport Inc (CYRX) - Net Assets
Based on the latest financial reports, Cryoport Inc (CYRX) has net assets worth $494.99 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($763.61 Million) and total liabilities ($268.62 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check CYRX tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $494.99 Million |
| % of Total Assets | 64.82% |
| Annual Growth Rate | N/A |
| 5-Year Change | -21.69% |
| 10-Year Change | 8748.63% |
| Growth Volatility | 112.12 |
Cryoport Inc - Net Assets Trend (2004–2025)
This chart illustrates how Cryoport Inc's net assets have evolved over time, based on quarterly financial data. See Cryoport Inc (CYRX) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Cryoport Inc (2004–2025)
The table below shows the annual net assets of Cryoport Inc from 2004 to 2025. For live valuation and market cap data, see Cryoport Inc stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $502.64 Million | +25.07% |
| 2024-12-31 | $401.90 Million | -17.82% |
| 2023-12-31 | $489.02 Million | -12.02% |
| 2022-12-31 | $555.84 Million | -13.40% |
| 2021-12-31 | $641.83 Million | +67.71% |
| 2020-12-31 | $382.70 Million | +203.05% |
| 2019-12-31 | $126.28 Million | +227.61% |
| 2018-12-31 | $38.55 Million | +115.50% |
| 2017-12-31 | $17.89 Million | +214.89% |
| 2016-12-31 | $5.68 Million | +13.83% |
| 2015-12-31 | $4.99 Million | +1298.72% |
| 2014-12-31 | $-416.30K | +81.94% |
| 2013-12-31 | $-2.30 Million | -11.69% |
| 2012-12-31 | $-2.06 Million | -155.32% |
| 2011-12-31 | $3.73 Million | -37.30% |
| 2010-12-31 | $5.95 Million | +750.40% |
| 2009-12-31 | $-914.58K | +75.17% |
| 2008-12-31 | $-3.68 Million | -61.01% |
| 2007-12-31 | $-2.29 Million | -16.66% |
| 2006-12-31 | $-1.96 Million | +8.79% |
| 2005-12-31 | $-2.15 Million | -82.20% |
| 2004-12-31 | $-1.18 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cryoport Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 68336721000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $50.00K | 0.01% |
| Other Comprehensive Income | $-3.48 Million | -0.69% |
| Other Components | $1.19 Billion | 237.74% |
| Total Equity | $502.64 Million | 100.00% |
Cryoport Inc Competitors by Market Cap
The table below lists competitors of Cryoport Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Placoplatre SA
PA:MLPLC
|
$685.48 Million |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
|
$685.59 Million |
|
CECEP Guozhen Environmental Protection Technology Co Ltd
SHE:300388
|
$685.65 Million |
|
Mobilicom Limited Warrants
NASDAQ:MOBBW
|
$685.76 Million |
|
GCM Grosvenor Inc
NASDAQ:GCMG
|
$685.35 Million |
|
SunCoke Energy Inc
NYSE:SXC
|
$684.94 Million |
|
Jiangsu Rainbow Heavy Industries Co Ltd
SHE:002483
|
$684.91 Million |
|
Shanghai Amarsoft Information & Technolgy Co Ltd
SHE:300380
|
$684.72 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cryoport Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 401,898,000 to 502,638,000, a change of 100,740,000 (25.1%).
- Net income of 78,301,000 contributed positively to equity growth.
- Dividend payments of 8,000,000 reduced retained earnings.
- Share repurchases of 10,011,000 reduced equity.
- Other comprehensive income increased equity by 17,446,000.
- Other factors increased equity by 23,004,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $78.30 Million | +15.58% |
| Dividends Paid | $8.00 Million | -1.59% |
| Share Repurchases | $10.01 Million | -1.99% |
| Other Comprehensive Income | $17.45 Million | +3.47% |
| Other Changes | $23.00 Million | +4.58% |
| Total Change | $- | 25.07% |
Book Value vs Market Value Analysis
This analysis compares Cryoport Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.47x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | $-7.38 | $14.76 | x |
| 2005-12-31 | $-8.05 | $14.76 | x |
| 2006-12-31 | $-7.35 | $14.76 | x |
| 2007-12-31 | $-8.28 | $14.76 | x |
| 2008-12-31 | $-10.00 | $14.76 | x |
| 2009-12-31 | $-2.04 | $14.76 | x |
| 2010-12-31 | $5.01 | $14.76 | x |
| 2011-12-31 | $1.44 | $14.76 | x |
| 2012-12-31 | $-0.61 | $14.76 | x |
| 2013-12-31 | $-0.53 | $14.76 | x |
| 2014-12-31 | $-0.08 | $14.76 | x |
| 2015-12-31 | $0.63 | $14.76 | x |
| 2016-12-31 | $0.40 | $14.76 | x |
| 2017-12-31 | $0.78 | $14.76 | x |
| 2018-12-31 | $1.37 | $14.76 | x |
| 2019-12-31 | $3.78 | $14.76 | x |
| 2020-12-31 | $9.92 | $14.76 | x |
| 2021-12-31 | $13.97 | $14.76 | x |
| 2022-12-31 | $12.10 | $14.76 | x |
| 2023-12-31 | $9.98 | $14.76 | x |
| 2024-12-31 | $8.25 | $14.76 | x |
| 2025-12-31 | $10.04 | $14.76 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cryoport Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 15.58%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 44.44%
- • Asset Turnover: 0.23x
- • Equity Multiplier: 1.52x
- Recent ROE (15.58%) is above the historical average (-42.84%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 0.00% | -382.46% | 0.25x | 0.00x | $-920.11K |
| 2005 | 0.00% | -999.42% | 0.52x | 0.00x | $-1.31 Million |
| 2006 | 0.00% | -999.42% | 0.40x | 0.00x | $-1.33 Million |
| 2007 | 0.00% | -3466.70% | 0.14x | 0.00x | $-2.10 Million |
| 2008 | 0.00% | -47560.50% | 0.02x | 0.00x | $-16.34 Million |
| 2009 | 0.00% | -4791.25% | 0.02x | 0.00x | $-5.56 Million |
| 2010 | -103.43% | -1293.84% | 0.04x | 1.85x | $-6.75 Million |
| 2011 | -210.03% | -1409.72% | 0.09x | 1.67x | $-8.21 Million |
| 2012 | 0.00% | -579.94% | 0.63x | 0.00x | $-6.18 Million |
| 2013 | 0.00% | -735.56% | 1.56x | 0.00x | $-19.33 Million |
| 2014 | 0.00% | -178.56% | 1.51x | 0.00x | $-6.99 Million |
| 2015 | -196.79% | -166.95% | 0.79x | 1.49x | $-10.32 Million |
| 2016 | -230.85% | -170.77% | 0.95x | 1.43x | $-13.68 Million |
| 2017 | -44.16% | -66.08% | 0.59x | 1.13x | $-9.69 Million |
| 2018 | -24.79% | -48.69% | 0.35x | 1.47x | $-13.41 Million |
| 2019 | -14.52% | -54.01% | 0.25x | 1.08x | $-30.96 Million |
| 2020 | -8.54% | -41.54% | 0.14x | 1.44x | $-70.96 Million |
| 2021 | -42.93% | -123.77% | 0.20x | 1.73x | $-339.71 Million |
| 2022 | -49.57% | -123.77% | 0.21x | 1.87x | $-331.11 Million |
| 2023 | -7.63% | -15.73% | 0.25x | 1.96x | $-86.24 Million |
| 2024 | -24.78% | -42.69% | 0.33x | 1.75x | $-139.78 Million |
| 2025 | 15.58% | 44.44% | 0.23x | 1.52x | $28.04 Million |
Industry Comparison
This section compares Cryoport Inc's net assets metrics with peer companies in the Integrated Freight & Logistics industry.
Industry Context
- Industry: Integrated Freight & Logistics
- Average net assets among peers: $75,817,727
- Average return on equity (ROE) among peers: -15.84%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cryoport Inc (CYRX) | $494.99 Million | 0.00% | 0.54x | $685.47 Million |
| Addentax Group Corp (ATXG) | $24.12 Million | 5.47% | 0.71x | $3.30 Million |
| Armlogi Holding Corp. Common Stock (BTOC) | $10.57 Million | 18.74% | 4.78x | $13.10 Million |
| CH Robinson Worldwide Inc (CHRW) | $517.03 Million | 22.07% | 0.76x | $21.08 Billion |
| Tianci International, Inc. Common Stock (CIIT) | $-278.63K | 0.00% | 0.00x | $3.21 Million |
| Callan JMB Inc. Common Stock (CJMB) | $3.17 Million | -72.28% | 0.60x | $4.17 Million |
| Freightos Limited Ordinary shares (CRGO) | $18.47 Million | -76.71% | 0.69x | $74.42 Million |
| Cheetah Net Supply Chain Service Inc. Class A Common Stock (CTNT) | $12.62 Million | -41.12% | 0.22x | $3.44 Million |
| Eastern International Ltd. (ELOG) | $9.05 Million | -10.34% | 1.26x | $11.73 Million |
| Expeditors International of Washington, Inc. (EXPD) | $87.60 Million | 11.64% | 0.65x | $19.44 Billion |
About Cryoport Inc
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic … Read more